The clinical significance of biochemical failure in the first 2 years in patients treated with neo-adjuvant androgen deprivation and radiotherapy for prostate cancer

Autor: Armstrong JG, O'Shea CM, Finn MA, Collins IM, Dunne MT, Fergal C Kelleher

Publikováno v: Research Journal of Infectious Diseases. 1:2

Lyme disease remains a controversial illness. The controversy is based on a profound disagreement over the existence of persistent infection with the Lyme spirochete, Borrelia burgdorferi, and the ability of this persistent infection to cause chronic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9b0e4b68d3a7c9e99a325c7d13374266
https://doi.org/10.7243/2052-5958-1-2

Early salvage hormonal therapy for biochemical failure improved survival in prostate cancer patients after neoadjuvant hormonal therapy plus radiation therapy-a secondary analysis of irish clinical oncology research group 97-01.

Autor: Mydin AR (AUTHOR), Dunne MT (AUTHOR), Finn MA (AUTHOR), Armstrong JG (AUTHOR)

Publikováno v: International Journal of Radiation Oncology, Biology, Physics. Jan2013, Vol. 85 Issue 1, p101-108. 8p.

Validation of the bladder neck as an important organ at risk in prostate seed brachytherapy based on D 2cc : A single-institution, retrospective review.

Autor: Wallace ND; Department of Radiation Oncology, Cork University Hospital, Ireland., Olden KL; Department of Radiation Oncology, Cork University Hospital, Ireland., Brennan VS; Memorial Sloan Kettering Cancer Center, New York, USA., Samuji MM; Bon Secours Radiotherapy Cork in partnership with UPMC Hillman Cancer Centre, Ireland., Jamaluddin MF; Department of Radiation Oncology, Cork University Hospital, Ireland., McVey G; Department of Radiation Oncology, St Luke's Radiation Oncology Network, Dublin, Ireland., Dunne MT; Clinical Trials Unit, St Luke's Radiation Oncology Network, Dublin, Ireland., Kelly PJ; Bon Secours Radiotherapy Cork in partnership with UPMC Hillman Cancer Centre, Ireland.

Publikováno v: Journal of contemporary brachytherapy [J Contemp Brachytherapy] 2023 Apr; Vol. 15 (2), pp. 96-102. Date of Electronic Publication: 2023 Mar 30.

Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.

Autor: Kishan AU; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA; Department of Urology, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: aukishan@mednet.ucla.edu., Sun Y; Department of Population Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA., Hartman H; Department of Population Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA., Pisansky TM; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Bolla M; Radiotherapy Department, University Hospital, Grenoble, France., Neven A; Statistics Department, European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium., Steigler A; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia., Denham JW; School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia., Feng FY; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA., Zapatero A; Hospital Universitario de la Princesa, Madrid, Spain., Armstrong JG; Cancer Trials Ireland and St Luke's Radiation Oncology Network, Dublin, Ireland., Nabid A; Department of Radiation Oncology, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada., Carrier N; Clinical Research Center, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada., Souhami L; Department of Radiation Oncology, McGill University Health Centre, Montréal, QC, Canada., Dunne MT; Cancer Trials Ireland and St Luke's Radiation Oncology Network, Dublin, Ireland., Efstathiou JA; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA., Sandler HM; Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Guerrero A; Hospital Son Espases, Palma de Mallorca, Spain., Joseph D; Department of Medicine and Surgery, University of Western Australia, Perth, WA, Australia., Maingon P; Department of Oncology, Hematology, and Supportive Care, Sorbonne University, Paris, France., de Reijke TM; Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands., Maldonado X; Hospital Universitari Vall d'Hebron, Barcelona, Spain., Ma TM; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA., Romero T; Division of General Internal Medicine and Health Services Research, University of California Los Angeles, Los Angeles, CA, USA., Wang X; Division of General Internal Medicine and Health Services Research, University of California Los Angeles, Los Angeles, CA, USA., Rettig MB; Department of Urology, University of California Los Angeles, Los Angeles, CA, USA; Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA; Department of Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA., Reiter RE; Department of Urology, University of California Los Angeles, Los Angeles, CA, USA., Zaorsky NG; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA., Steinberg ML; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA., Nickols NG; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA; Department of Urology, University of California Los Angeles, Los Angeles, CA, USA., Jia AY; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Garcia JA; Division of Oncology, Seidman Cancer Center, Cleveland, OH, USA., Spratt DE; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA. Electronic address: daniel.spratt@uhhospitals.org.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2022 Feb; Vol. 23 (2), pp. 304-316. Date of Electronic Publication: 2022 Jan 17.

The effect of anaemia on normal tissue toxicity and survival outcomes in prostate cancer treated with radical radiotherapy and neo-adjuvant androgen deprivation.

Autor: Keenan LG; Cancer Trials Ireland (formally All-Ireland Cooperative Oncology Research Group, ICORG), Dublin, Ireland.; St Lukes Radiation Oncology Network, Oakland Drive, Highfield Road, Rathgar, Dublin, Ireland., Ibrahim N; St Lukes Radiation Oncology Network, Oakland Drive, Highfield Road, Rathgar, Dublin, Ireland., Dunne MT; Cancer Trials Ireland (formally All-Ireland Cooperative Oncology Research Group, ICORG), Dublin, Ireland.; St Lukes Radiation Oncology Network, Oakland Drive, Highfield Road, Rathgar, Dublin, Ireland., Finn M; St Lukes Radiation Oncology Network, Oakland Drive, Highfield Road, Rathgar, Dublin, Ireland., Armstrong JG; Cancer Trials Ireland (formally All-Ireland Cooperative Oncology Research Group, ICORG), Dublin, Ireland.; St Lukes Radiation Oncology Network, Oakland Drive, Highfield Road, Rathgar, Dublin, Ireland.

Publikováno v: The British journal of radiology [Br J Radiol] 2020 Apr; Vol. 93 (1108), pp. 20190577. Date of Electronic Publication: 2020 Jan 29.